FDA approves new weight-loss drug Qsymia

This transcript is automatically generated

You the FDA approving a new weight loss drug called -- semi -- It's a second diet pill approved in less than a month just three weeks ago the drug -- that was approved for the same purpose.

-- these drugs even work and what are the risks I would doctor Siegel I'm I'm.

Mental telepathy you're gonna tell -- diet and exercise but for those of us who want an easier way could these work.

I would tell everybody -- their diet and exercise do it and lifestyle change.

Bottom also gonna tell you that for people that come to me -- high blood pressure and diabetes risk of stroke.

Heart disease a lot of the reason is often that -- there's obesity one out of three adults in the United States already obese we've got to do something.

I'm already prescribing the drug phentermine which is part of -- ceemea.

That's one half of the drug and I use that a lot I use that -- people that can exercise or that have tried exercise that's half of -- -- that was ever fen -- but that's the half of fen Phen that was not.

The part that got it in the drug in trouble okay so I'm very comfortable with the -- in part my problem with this although I'm very glad the FDA approved this because.

It has been shown to be quite effective for weight loss.

And it should be an arrow in our quiver but I have a general problem with combo drugs because -- I can't always tell if there is a problem.

Which of the two is causing in the thing that the FDA is keeping a very close eye on is the other drug in this hope you're -- -- -- pyramid is the other part of this commonly noticed over -- That -- -- -- for migraines it's used for headaches we noticed that helps with weight loss but he can make you think a little more slowly it can make you fatigue.

And it may be can cause birth defects so we don't want pregnant women to be taking this it's a cautionary flag but I'm glad the arrow is there in the quiver.

-- -- -- Love this story behind this is that they came in the market would be applied to afternoon 2010.

It got rejected because of the side effects as -- they went back to the more than they decided what how we going to get this back in the system.

Now this you have to look at the balance between the risk of obesity and what he does to cardiovascular blood pressure and cholesterol.

And the risk of these medications which is kidney stone could be.

-- -- face could be memory loss.

Cardiovascular issues so FDA looked at both risk and decided that the risk of obesity outweighs the risk of his medications.

-- now it's coming into the market.

Now there's a guideline for this you can just go to the pharmacy and -- I need this medication.

You have to be really obese body -- over thirty.

Or if you're overweight and has one of these cholesterol blood pressure diabetes then -- a candidate.

This side effects are there are you really have to your doctor before you take it and for people that just want to have the casual weight loss to go to the beach this is a wrong one.

If you are way overweight.

10% nobody of their losses actually can help you tremendously -- keep us posted both -- view on patients you know and how effective it is so.

Watch Live

FDA approves new weight-loss drug Qsymia

Details

Clips

Sunday Housecall

Serious new questions about preemptive surgeries

Ways to reduce your stroke risk

Lap-band surgery: risks and benefits

Scientists predict future cure for grey hair

FDA wants cancer warnings on tanning beds

Report: Heart risk factors affect brain function

Back pain: Ways to strengthen your spine

Study: Brain region found to control aging

May is Melanoma Awareness Month

Tips to quit smoking

40 percent of parents giving kids unneeded cold medicines

The power of exercise

Transcript

Recommended